A new guidance document released this week by the US Food and Drug Administration (FDA) aims to clarify the interaction of the 2012 Biologics Price Competition and Innovation Act (BPCI) and the 1983 ...
FairJourney Bio ("FJBio"), a global antibody discovery expert, has announced the program for The Antibody Series (TAS) 2026, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results